IGC Pharma (NYSE American: IGC) Alzheimer’s Drug Gains Attention After Ascendiant Capital Raises Price Target
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage biotechnology company focused on Alzheimer’s disease, artificial intelligence, and drug discovery, is drawing renewed investor attention after Ascendiant Capital reiterated its BUY rating…
